NCT02837042 2022-06-21Trial of Pembrolizumab for Advanced Penile Squamous Cell CarcinomaUniversity of Alabama at BirminghamPhase 2 Terminated6 enrolled 10 charts
NCT03544723 2020-06-09Safety and Efficacy of p53 Gene Therapy Combined With Immune Checkpoint Inhibitors in Solid Tumors.MultiVir, Inc.Phase 2 Unknown40 enrolled